25
Jun 2019
‘Game changing’ cancer drugs to be fast-tracked by NHS
Two drugs which are known as tumour agnostics, could be available on the NHS later this year, offering hope to patients with hard to treat or rare cancers. In trials, 75 per cent of tumours responded to the drugs, which target tumours according to their genetic make-up, rather than their location in the body, and…